Literature DB >> 24573875

Association of the genetic polymorphism of EPHX1 and EPHX2 with the susceptibility to chronic benzene poisoning.

Pin Sun1, Zhongbin Zhang, Fen Wu, Junxiang Wan, Xibeng Jin, Zhaolin Xia.   

Abstract

The aim of this study was to explore the association of the genetic polymorphism of EPHX1 and EPHX2 with the susceptibility to chronic benzene poisoning (CBP). A case-control study of 268 patients with CBP and 268 healthy workers matched by age and sex, all of whom were occupationally exposed to benzene, was conducted. The single nucleotide polymorphisms (SNPs, rs2854451, rs3738047, rs2234922 and rs1051741) of EPHX1 gene and the SNP (rs751141) of EPHX2 gene were tested by the TaqMan PCR method. In the subjects carrying the genotype of EPHX1 rs3738047 GG, the risk of CBP was decreased in the individuals simultaneously carrying EPHX1 rs2234922 G (P = 0.02). Alternatively, in the subjects carrying the genotype of EPHX1 rs2234922 AA, the risk of CBP was increased in the individuals simultaneously carrying the allele of EPHX2 rs751141A (P = 0.03). It was also found that there were potential interactions between alcohol consumption and the polymorphism of EPHX1 rs1051741 (χH (2) = 5.28, P = 0.02) or rs2234922 (χH (2) = 6.71, P = 0.01). Compared to individuals with EPHX1 rs1051741 CC or rs2234922 AA genotype in the drinkers, the risk of CBP in those carrying genotypes of EPHX1 rs1051741 CT+TT or rs2234922 AG+GG was decreased, respectively (P = 0.04, P < 0.01). Haplotype analysis of polymorphisms in EPHX1 showed that the risk of CBP was increased in the subjects with haplotype 2 (rs2854451-A, rs3738047-G, rs2234922-A, rs1051741-C) or haplotype 4 (rs2854451-G, rs3738047-A, rs2234922-G, rs1051741-T), but decreased in those with haplotype 6 (rs2854451-G, rs3738047-G, rs2234922-G, rs1051741-T) or haplotype 10 (rs2854451-A, rs3738047-A, rs2234922-G, rs1051741-T), respectively. Logistic regression analysis revealed that smoking might play a role in modifying the risk of CBP (OR = 0.313, 95% CI: 0.123-0.794, P = 0.015). The genetic polymorphism in EPHX1 may be associated with the risk of CBP in the Chinese occupational population and further research is needed for the association between the genetic polymorphism in EPHX2 and the susceptibility to CBP.

Entities:  

Year:  2007        PMID: 24573875     DOI: 10.1007/s11684-007-0062-y

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  22 in total

1.  Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.

Authors:  E W Tiemersma; R E Omer; A Bunschoten; P van't Veer; F J Kok; M O Idris; A M Kadaru; S S Fedail; E Kampman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

Review 2.  Epoxide hydrolases: biochemistry and molecular biology.

Authors:  A J Fretland; C J Omiecinski
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

3.  Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.

Authors:  A G Casson; Z Zheng; D Chiasson; K MacDonald; D C Riddell; J R Guernsey; D L Guernsey; J McLaughlin
Journal:  Cancer Detect Prev       Date:  2003

Review 4.  The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast.

Authors:  L A Mucci; S Wedren; R M Tamimi; D Trichopoulos; H O Adami
Journal:  J Intern Med       Date:  2001-06       Impact factor: 8.989

5.  Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression.

Authors:  J L Valentine; S S Lee; M J Seaton; B Asgharian; G Farris; J C Corton; F J Gonzalez; M A Medinsky
Journal:  Toxicol Appl Pharmacol       Date:  1996-11       Impact factor: 4.219

6.  Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms.

Authors:  M Sandberg; C Hassett; E T Adman; J Meijer; C J Omiecinski
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

7.  Polymorphisms in human soluble epoxide hydrolase.

Authors:  Beata D Przybyla-Zawislak; Punit K Srivastava; Johana Vazquez-Matias; Harvey W Mohrenweiser; Joseph E Maxwell; Bruce D Hammock; J Alyce Bradbury; Ahmed E Enayetallah; Darryl C Zeldin; David F Grant
Journal:  Mol Pharmacol       Date:  2003-08       Impact factor: 4.436

8.  The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization.

Authors:  C Hassett; K B Robinson; N B Beck; C J Omiecinski
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

9.  Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization.

Authors:  R C Skoda; A Demierre; O W McBride; F J Gonzalez; U A Meyer
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

10.  Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk.

Authors:  A Gsur; T Zidek; K Schnattinger; E Feik; G Haidinger; P Hollaus; A Mohn-Staudner; C Armbruster; S Madersbacher; G Schatzl; K Trieb; C Vutuc; M Micksche
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more
  1 in total

1.  Platelet mitochondrial cytochrome c oxidase subunit I variants with benzene poisoning.

Authors:  Dianpeng Wang; Xiangli Yang; Yanfang Zhang; Dafeng Lin; Paimao Li; Zhiming Zhang; Xianqing Huang; Dayong Gu; Jacky Fong-Chuen Loo
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.